Simon Spichak

Last year, researchers in Ontario, Canada started recruiting participants for a Long COVID trial testing the feasibility of exercise and rehabilitation. Like many other studies of exercise, it doesn’t use validated measures for post-exertional malaise (PEM). But the Pursuing Reduction in Fatigue After COVID-19 via Exercise and Rehabilitation (PREFACER) study, run by researchers at Western University, stands out because it involves deceiving participants — undermining informed consent and potenti

Understand the impacts of how new AI tools are reshaping Canada’s benefits system on transparency and accountability for citizens.

One NIH study will test low-dose naltrexone, while other upcoming trials will test larozitide and taurine.

An analysis by The Sick Times find that less than 15% of Long COVID clinical trials testing the benefits of exercise or cardiopulmonary rehabilitation measured post-exertional malaise, according to their trial registration, while a handful excluded participants who experience it.

Guidelines recommend exercise and therapy as treatments, following attempted influence from Paul Garner.

Experts who spoke with The Sick Times brought up many different reasons why developing new drugs for children with Long COVID has moved at such a glacial pace. Many pharmaceutical companies might not see Long COVID as profitable. And running trials in children is complex and expensive, as they can have different symptoms and underlying biological processes behind those symptoms from adults. “I want more clinical trials focused on cures and effective treatments. We want treatments that are actual

MAiD’s expansion to include mental health may be on indefinite hold, but the government has still done nothing to help people live

Research shows there are simple interventions that could help protect students and staff from illness and other harms. Advocates say Ontario needs to do more.

People with Long Covid in the U.S., Canada, U.K., and Europe are buying billboard ads to raise awareness about the disease and promote the urgent need for clinical trials. These billboards aim to do the job of public health authorities, advocates who spoke to The Sick Times explained. However, as some billboard efforts in the U.S. have run into roadblocks, legal experts say there’s a potential case that advocates may be experiencing discrimination under the Americans with Disabilities Act (ADA).

A Vancouver woman says she will die imminently from an otherwise manageable illness

Thousands of Ontarians are dealing with significant post-COVID symptoms and are desperate for answers. Where can they turn?